Holdings of iShares Genomics Immunology and Healthcare ETF
iShares Trust · Original filing · Compare with another fund · Report an error
- Net assets
- 190.9M $ including 183.3M $ in equities, 96.0 %
- Positions
- 49 in 12 countries
- Top ten
- 43.0 % of net assets
- Filed on
- Jul 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Bayer AG | 165,508 | 9.2M $ | 4.81 % |
| 2 | TWIST BIOSCIENCE CORP | 99,937 | 9.1M $ | 4.79 % |
| 3 | REVOLUTION MEDICINES INC | 46,352 | 8.7M $ | 4.55 % |
| 4 | Regeneron Pharmaceuticals Inc | 10,887 | 8.3M $ | 4.35 % |
| 5 | Genmab A/S | 28,069 | 8.1M $ | 4.23 % |
| 6 | Incyte Corp | 67,570 | 8.1M $ | 4.23 % |
| 7 | MODERNA INC | 145,819 | 8M $ | 4.19 % |
| 8 | Takeda Pharmaceutical Co Ltd | 225,100 | 7.7M $ | 4.05 % |
| 9 | Merck & Co Inc | 57,270 | 7.5M $ | 3.91 % |
| 10 | Vertex Pharmaceuticals Inc | 15,481 | 7.4M $ | 3.87 % |
| 11 | Roche Holding AG | 16,796 | 7.3M $ | 3.85 % |
| 12 | Ipsen SA | 37,928 | 7.3M $ | 3.84 % |
| 13 | Exelixis Inc | 131,275 | 7M $ | 3.65 % |
| 14 | GSK PLC | 266,670 | 6.9M $ | 3.63 % |
| 15 | Sanofi SA | 76,788 | 6.6M $ | 3.46 % |
| 16 | Ideaya Biosciences Inc | 180,483 | 6.4M $ | 3.36 % |
| 17 | IMMUNITYBIO INC | 817,183 | 5.9M $ | 3.07 % |
| 18 | ARCUS BIOSCIENCES INC | 181,763 | 5.1M $ | 2.68 % |
| 19 | CARIS LIFE SCIENCES INC | 266,135 | 4.2M $ | 2.19 % |
| 20 | Ono Pharmaceutical Co Ltd | 244,500 | 3.7M $ | 1.91 % |
| 21 | Iovance Biotherapeutics Inc | 841,830 | 3.4M $ | 1.80 % |
| 22 | Nuvation Bio Inc | 536,281 | 3.4M $ | 1.78 % |
| 23 | CRISPR Therapeutics AG | 62,247 | 3M $ | 1.57 % |
| 24 | ABCELLERA BIOLOGICS INC | 508,935 | 2.9M $ | 1.52 % |
| 25 | Vir Biotechnology Inc | 289,265 | 2.5M $ | 1.31 % |
| 26 | Novavax Inc | 339,643 | 2.5M $ | 1.30 % |
| 27 | Janux Therapeutics Inc | 124,166 | 1.9M $ | 0.99 % |
| 28 | Sunshine Lake Pharma Co Ltd | 351,500 | 1.9M $ | 0.98 % |
| 29 | Corvus Pharmaceuticals Inc | 137,099 | 1.8M $ | 0.95 % |
| 30 | Personalis Inc | 134,479 | 1.7M $ | 0.89 % |
| 31 | Kura Oncology Inc | 186,448 | 1.7M $ | 0.88 % |
| 32 | GenFleet Therapeutics Shanghai Inc | 419,200 | 1.5M $ | 0.78 % |
| 33 | Rigel Pharmaceuticals Inc | 38,807 | 1.4M $ | 0.75 % |
| 34 | CYTOMX THERAPEUTICS INC | 375,908 | 1.2M $ | 0.61 % |
| 35 | VERASTEM INC | 178,719 | 1M $ | 0.54 % |
| 36 | Alvotech SA | 244,900 | 1M $ | 0.53 % |
| 37 | Design Therapeutics Inc | 81,808 | 996.4K $ | 0.52 % |
| 38 | Xencor Inc | 48,671 | 983.6K $ | 0.52 % |
| 39 | Intellia Therapeutics Inc | 91,888 | 981.4K $ | 0.51 % |
| 40 | Shanghai Henlius Biotech Inc | 135,900 | 964.1K $ | 0.51 % |
| 41 | Ocugen Inc | 723,783 | 890.3K $ | 0.47 % |
| 42 | Pacific Biosciences of California Inc | 622,048 | 870.9K $ | 0.46 % |
| 43 | VALNEVA SE | 349,239 | 866.3K $ | 0.45 % |
| 44 | Ginkgo Bioworks Holdings Inc | 101,324 | 819.7K $ | 0.43 % |
| 45 | ABCLON INC | 34,319 | 469.8K $ | 0.25 % |
| 46 | PRIME MEDICINE INC | 65,480 | 191.2K $ | 0.10 % |
| 47 | ARCELLX INC CVR | 73,059 | 5.1K $ | 0.00 % |
| 48 | OmniAb Inc | 19,498 | 0.2 $ | |
| 49 | OmniAb Inc | 19,498 | 0.2 $ |
Sector breakdown
- Health care 42.0 %
- Unattributed 58.0 %
Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".
Currency breakdown
- USD 65.9 %
- EUR 13.1 %
- JPY 6.2 %
- DKK 4.4 %
- CHF 4.0 %
- GBP 3.8 %
- HKD 2.4 %
- KRW 0.3 %
Each line is counted in its quoted currency, as the fund declares it.
Country breakdown
- United States 62.1 %
- France 8.1 %
- Japan 6.2 %
- Switzerland 5.6 %
- Germany 5.0 %
- Denmark 4.4 %
- United Kingdom 3.8 %
- Hong Kong SAR China 1.8 %
- Canada 1.6 %
- Iceland 0.6 %
- China 0.5 %
- South Korea 0.3 %
Shares are computed on the fund's equities only.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 33 | 113.8M $ | 62.12 % |
| 2 | France | 3 | 14.8M $ | 8.08 % |
| 3 | Japan | 2 | 11.4M $ | 6.21 % |
| 4 | Switzerland | 2 | 10.3M $ | 5.64 % |
| 5 | Germany | 1 | 9.2M $ | 5.01 % |
| 6 | Denmark | 1 | 8.1M $ | 4.41 % |
| 7 | United Kingdom | 1 | 6.9M $ | 3.78 % |
| 8 | Hong Kong SAR China | 2 | 3.4M $ | 1.83 % |
| 9 | Canada | 1 | 2.9M $ | 1.59 % |
| 10 | Iceland | 1 | 1M $ | 0.55 % |
| 11 | China | 1 | 964.1K $ | 0.53 % |
| 12 | South Korea | 1 | 469.8K $ | 0.26 % |
Cite this page
Titelia. "Holdings of iShares Genomics Immunology and Healthcare ETF". https://titelia.com/en/funds/S000065599